David Silberstein
Direktor/Vorstandsmitglied bei LANTERN PHARMA INC.
Vermögen: - $ am 31.05.2024
Aktive Positionen von David Silberstein
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| LANTERN PHARMA INC. | Direktor/Vorstandsmitglied | 01.06.2018 | - |
| Independent Dir/Board Member | 01.06.2018 | - | |
BioMimetix Pharmaceutical, Inc.
 BioMimetix Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Omni Bio Pharmaceutical, Inc., BioMimetix Pharmaceutical, Inc. provides development services for biopharmaceutical products. The company is based in Greenwood Village, CO. BioMimetix Pharmaceutical was acquired by Omni Bio Pharmaceutical, Inc. on July 21, 2011 for $2 million. | Geschäftsführer | 01.01.2013 | - |
Biological Mimetics, Inc.
 Biological Mimetics, Inc. Pharmaceuticals: MajorHealth Technology Biological Mimetics, Inc. engages in the provision of pharmaceutical products. It offers deceptive imprinting, vaccines, dampening, refocusing, and therapeutic antibodies. The company was founded by Peter L. Nara in 1996 and is headquartered in Frederick, MD. | Direktor/Vorstandsmitglied | 01.01.2016 | - |
Karriereverlauf von David Silberstein
Ausbildung von David Silberstein
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| 2 |
Operativ
| Director/Board Member | 2 |
| Independent Dir/Board Member | 1 |
| Chief Operating Officer | 1 |
Sektoral
| Commercial Services | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
| Lantern Pharma, Inc. | |
BioMimetix Pharmaceutical, Inc.
BioMimetix Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Omni Bio Pharmaceutical, Inc., BioMimetix Pharmaceutical, Inc. provides development services for biopharmaceutical products. The company is based in Greenwood Village, CO. BioMimetix Pharmaceutical was acquired by Omni Bio Pharmaceutical, Inc. on July 21, 2011 for $2 million. | Commercial Services |
Biological Mimetics, Inc.
Biological Mimetics, Inc. Pharmaceuticals: MajorHealth Technology Biological Mimetics, Inc. engages in the provision of pharmaceutical products. It offers deceptive imprinting, vaccines, dampening, refocusing, and therapeutic antibodies. The company was founded by Peter L. Nara in 1996 and is headquartered in Frederick, MD. | Health Technology |
- Börse
- Insiders
- David Silberstein
- Erfahrung
